\
&
Contact us
\
&
Contact us
Published on | 3 years ago
ProgrammesThe results of the mission call Support the deployment of lighthouse demonstrators for the New European Bauhaus initiative in the context of Horizon Europe missions (HORIZON-MISS-2021-NEB-01) are announced. Five projects have been selected for this call and will each receive a funding of approximately €5 million to implement their plans in 13 EU Member States and Associated Countries: Belgium, Czechia, Germany, Denmark, Greece, Croatia, Italy, Latvia, Netherlands, Slovenia, Portugal, Norway and Turkey.
The selected projects will bring innovative ideas and solutions in helping to point the way forward for other New European Bauhaus actions and will also contribute to the EU Missions.
To read the full press release click here.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
Security Digital, Industry & Space Cybersecurity
The EU introduced a new ICT Supply Chain Security Toolbox, providing an EU approach to identify, assess, and mitigate cybersecurity risks across ICT supply chains. The toolbox will help Member States and public and private actors to bolster the security of ICT supply chains in the EU as set out in the revised Cybersecurity Act presented... read more
The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.
